[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-366505-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-366505-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","human-papillomavirus-infection-among-patients-with-cervical-cancer-in-cambodia","Human papillomavirus infection among patients with cervical cancer in Cambodia","","Retrospective, observational, cross-sectional analysis was used to characterize human papillomavirus (HPV) infection patterns among patients with cervical cancer in Cambodia, supporting evaluation of a newly introduced HPV vaccination program. Fifty archival formalin-fixed paraffin-embedded cervical tumor specimens (April 2019 to March 2020) were profiled with next-generation sequencing. Forty-seven controls from non-oncological hysterectomies (January 2020 to March 2021) were assessed by PCR, gel electrophoresis, and p16 immunohistochemistry, with HPV-positive samples further sequenced.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/human-papillomavirus-infection-among-patients-with-cervical-cancer-in-cambodia/366505/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/human-papillomavirus-infection-among-patients-with-cervical-cancer-in-cambodia/366505.png","ImageObject",300,407,{"name":42,"@type":43},"Aran","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-13","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the study’s purpose in Cambodia?","Question",{"text":63,"@type":64},"To determine HPV type prevalence among patients with cervical cancer in Cambodia, providing epidemiological evidence to assess and optimize the country’s HPV vaccination policy.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were HPV types detected in cancer and control specimens?",{"text":68,"@type":64},"Cancer tumor specimens were analyzed using next-generation sequencing. Control specimens were first tested with PCR, gel electrophoresis, and p16 immunohistochemistry, and HPV-positive controls were then sequenced to identify HPV subtypes.",{"name":70,"@type":61,"acceptedAnswer":71},"Which HPV types were most commonly detected?",{"text":72,"@type":64},"HPV-16/18 were detected in 83.3% of cervical cancer specimens, HPV-58 in 11.9%, and multiple HPV subtypes were found in 2.4% of cancer specimens.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},366505,1790197148,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":115,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},137455076865,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Gardner et al. BMC Women's Health (2025) 25:413 BMC Women's Health  \n[https://doi.org/10.1186/s12905-025-03954-2](https://doi.org/10.1186/s12905-025-03954-2)  \nRESEARCH Open Access  \nHuman papillomavirus infection among patients with cervical cancer in Cambodia  \nJacob E. Gardner 1,2*, Kyle Jung2, Michel Pluot3, Tracy Sherertz4, Andrew Berchuck5, Rath Beauta 1, Huy Chankong6, Yi Ratana 1, Sarameth Thou 1, Aun Korn7, Phok Ratana7, Sanine Lay7, Pheng Meth7, Sokchann Khan7, Kalyan Meng7, Chhorvathany Ay7, Karuna Garg8 and Jae Jung2  \nAbstract  \nBackground Cervical cancer is the second-most common cancer among Cambodian women, with an estimated 1274 new cases and 670 deaths annually. On October 5, 2023, the Cambodian government introduced HPV vaccination for 9-year-old girls into the country’s national immunization schedule. The optimal strategy for this nascent vaccination campaign, and the expected effects thereof, depend on a robust understanding of HPV epidemiology in Cambodia. To this end, we conducted a retrospective, observational, cross-sectional study of HPV infection among patients with cervical cancer at Cal mette Hospital in Phnom Penh, Cambodia.  \nMethods Fifty specimens of formal in-fixed, paraffin-embedded cervical tumor tissue selected from archival specimens of biopsies performed at Cal mette Hospital between April 2019 to March 2020 were analyzed using nextgeneration sequencing to detect HPV types present in each sample. Forty-seven samples of non-cancerous cervical tissue were selected for comparison from archival specimens of non-oncological hysterectomies performed at Cambodia’s National Maternal and Child Health Center between January 2020 to March 2021 and analyzed using PCR, gel electrophoresis, and p16 immunohistochemistry to detect the presence of HPV infection in each sample. Those that tested positive for HPV underwent next generation sequencing to detect which HPV subtypes were present in each sample.  \nResults HPV-16/18 were detected in 83. 3% of cervical cancer specimens, and HPV-58 was detected in 11. 9% . Multiple HPV subtypes were detected in 2.4% of cancer specimens. Neither HPV-16 nor − 18 differed statistically in observed prevalence from either those rates reported for all Asia or globally. The observed prevalence of HPV-58 was not dissimilar between Cambodia and Asia, however Cambodia’s prevalence of HPV-58 was substantially higher than the global rate. HPV DNA was detected in 0/47 control specimens.  \nConclusion This is the first study of HPV type prevalences among patients with cervical cancer in Cambodia, providing epidemiological data that is crucial for assessing and optimizing the country’s vaccination policy. Results suggest that the efficacy of current vaccination strategy should not be hindered by any outsized prevalence of nonvaccine type HPV.  \nKeywords Cambodia, Cervical cancer, Human papillomavirus, Epidemiology  \n*Correspondence:  \nJacob E. Gardner [jacgardner@montefiore.org](jacgardner@montefiore.org)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission ","cbCaioqftcrSdG6I","https://ap.wps.com/l/cbCaioqftcrSdG6I","pdf",1476203,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Main Text Sections\n## Background on cervical cancer and HPV in Cambodia\n## HPV vaccination introduction and epidemiology knowledge gaps\n## Rationale for assessing HPV subtype prevalence","[{\"question\":\"What was the study’s purpose in Cambodia?\",\"answer\":\"To determine HPV type prevalence among patients with cervical cancer in Cambodia, providing epidemiological evidence to assess and optimize the country’s HPV vaccination policy.\"},{\"question\":\"How were HPV types detected in cancer and control specimens?\",\"answer\":\"Cancer tumor specimens were analyzed using next-generation sequencing. Control specimens were first tested with PCR, gel electrophoresis, and p16 immunohistochemistry, and HPV-positive controls were then sequenced to identify HPV subtypes.\"},{\"question\":\"Which HPV types were most commonly detected?\",\"answer\":\"HPV-16/18 were detected in 83.3% of cervical cancer specimens, HPV-58 in 11.9%, and multiple HPV subtypes were found in 2.4% of cancer specimens.\"}]","Human papillomavirus infection among patients with cervical cancer in Cambodia | PDF",1790165834,23,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0f3050b0a28125ad80bacc5e83048f67.webp",983,1310,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a648732bd90ba1c551446b8f093af6eb.webp",982,1309,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fc790065a5a91310b9073b2453fabb74.webp",981,1308,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1e8ca7cabe62c7dbff4eece97bcca13a.webp",980,1306]